To The Moon

$Moderna, Inc.(MRNA)$Just remember all biotech company play on result, sales and news. Vaccine sales will last for a year or 2 but after that, the pipeline for the next product at least few years to be approve to generate yearly revenue. Moderna has many research in the pipeline but just one approved product. Typical Vaccine take about 10 years to get approve so dont expect all to be fast track.

Futures rise amid earnings optimism; Dollar dips. Square, Moderna, First Solar and more made the big

President Joe Biden waved off long-term inflation concerns on Wednesday, telling aCNNtown hall in Ci

New York When the market is plunging like it did last Friday and on Monday, it's tempting to throw in the towel and sell. Big drops can be scary.But dumping stocks on days when the Dow is getting whacked is usually the wrong thing to do. Stocks roared back Tuesday and were up again Wednesday.If you're investing for the long haul, the best thing you can do is ride out this wave of volatility."Stay invested," said Seema Shah, chief strategist at Principal Global Investors. Shah told CNN Business t

Summary First, I explain Zevia as an emerging growth company. Second, I show Zevia's primary busine

Second-quarter earnings season picks up this week, as 76 S&P 500 companies are scheduled to report.

These stocks have dividend yields that are at least three times as high as the yields on 10-year U.S

These growth and value stocks are begging to be bought by investors.

Stock in electric-vehicle pioneer Tesla is on fire for seemingly no reason.There haven’t been any big,splashy upgrades that can explain the recent run. Shares have jumped almost 8% for the week and are on pace for their best week since April.Investors, rightly so, are wondering what’s going on. We found four reasons, outlined below.Many electric-vehicle stocks have been on a winning streak lately, beyond just Tesla. Coming into the week, shares of Chinese EV maker NIO were up 17% for the month.X